2015
DOI: 10.1016/j.nic.2014.09.011
|View full text |Cite
|
Sign up to set email alerts
|

Neuroimaging and Genetic Influence in Treating Brain Neoplasms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 55 publications
0
2
0
Order By: Relevance
“…These neoplasms represent some of the deadliest malignant tumors, are refractory to treatment and impact the quality of life of patients and caregivers 1 . Estimated worldwide incidence is 10.82 per 100,000 population every year, with intracranial metastases being up to 10 times more common than primary neoplasms 2,3 , followed in frequency by meningiomas and gliomas with an incidence of 7.72 and 3.2 per 100,000 population, respectively [4][5][6] . Glioblastoma (GBM), previously known as glioblastoma multiforme due to its complex histological image, represents the most common primary malignant tumor of the CNS, accounting for 16% of all primary intracranial neoplasms, but for 45.6% of the malignant ones 7,8 .…”
Section: Introductionmentioning
confidence: 99%
“…These neoplasms represent some of the deadliest malignant tumors, are refractory to treatment and impact the quality of life of patients and caregivers 1 . Estimated worldwide incidence is 10.82 per 100,000 population every year, with intracranial metastases being up to 10 times more common than primary neoplasms 2,3 , followed in frequency by meningiomas and gliomas with an incidence of 7.72 and 3.2 per 100,000 population, respectively [4][5][6] . Glioblastoma (GBM), previously known as glioblastoma multiforme due to its complex histological image, represents the most common primary malignant tumor of the CNS, accounting for 16% of all primary intracranial neoplasms, but for 45.6% of the malignant ones 7,8 .…”
Section: Introductionmentioning
confidence: 99%
“…Of the glial tumors, GBM is the most frequent, representing approximately 50–60% of astrocytomas [6]. The prognosis of GBM is dismal, with a survival rate less than one year despite current therapeutic advances.…”
Section: Discussionmentioning
confidence: 99%